| Literature DB >> 3349150 |
A L Pukhal'skiĭ, A P Mezhneva, L A Pevnitskiĭ.
Abstract
A method of quantitative evaluation of lymphocytes' sensitivity to the antiproliferative effect of the alkylating drugs has been developed. Chlorbutin, mafosfamide (Asta Z 7654) and "active" metabolites of cyclophosphamide were studied. This research allowed to distinguish more sensitive strains (DBA/2 and C57BL/6) and those with low sensitivity (BALB/c and CC57BR). These differences do not depend on proliferation reaction, neither on the type of alkylating drugs nor haplotypes H-2.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3349150
Source DB: PubMed Journal: Biull Eksp Biol Med ISSN: 0365-9615